Immunocore
IMCR
IMCR
66 hedge funds and large institutions have $770M invested in Immunocore in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.96% more ownership
Funds ownership: 45.01% → 47.97% (+3%)
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
59% less call options, than puts
Call options by funds: $2.87M | Put options by funds: $7.08M
Holders
66
Holding in Top 10
5
Calls
$2.87M
Puts
$7.08M
Top Buyers
| 1 | +$79.7M | |
| 2 | +$6.28M | |
| 3 | +$4.46M | |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$2.73M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.4M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$11.4M | |
| 3 | -$9.97M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$5.98M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
-$4.22M |